Top Qs
Timeline
Chat
Perspective

3,4-Dimethoxyamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

3,4-Dimethoxyamphetamine
Remove ads

3,4-Dimethoxyamphetamine (3,4-DMA), or simply dimethoxyamphetamine (DMA), is a psychedelic drug of the phenethylamine and amphetamine families.[1][2] It is one of the dimethoxyamphetamine (DMA) series of positional isomers.[1][2]

Quick Facts Clinical data, Other names ...
Remove ads

The drug has been assessed in various biochemical and preclinical studies.[2] It has been tried in humans at doses of up to 700 mg intravenously, with mescaline-like effects reported.[2][1] 3,4-DMA is also orally active and has produced sympathomimetic effects at a dose of 160 mg.[2][1] Its duration of action is unknown.[2][1]

Its affinity (Ki) for the rat serotonin 5-HT2A receptor has been assessed[2] and was found to be 43,300 nM.[3] For comparison, the affinity of para-methoxyamphetamine (PMA) was 33,600 nM, of 2,5-dimethoxyamphetamine (2,5-DMA) was 5,200 nM, and of 2,5-dimethoxy-4-methylamphetamine (DOM) was 100 nM in the same study.[3] 3,4-DMA has been found to be a monoamine oxidase inhibitor (MAOI), with an IC50Tooltip half-maximal inhibitory concentration of 20,000 nM for monoamine oxidase A (MAO-A), whereas it was inactive at monoamine oxidase B (MAO-B) (IC50 > 100,000 nM).[4][5]

3,4-DMA fails to produce stimulus generalization to dextroamphetamine in rodent drug discrimination tests, suggesting that it lacks psychostimulant- or amphetamine-like effects.[6]

3,4-DMA produces 3-methoxy-4-hydroxyamphetamine (MHA) as its major metabolite in dogs and monkeys.[2]

Remove ads

See also

References

Loading content...
Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads